Skip to main content
Caplight Logo









Zoundream

Zoundream

Private
BaselHealthcare & Life Scienceshttps://zoundream.com/

Last Round

Seed

Oct 3, 2025

Total Funding Raised

$4.68M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Zoundream is a health-tech company that provides an AI-driven platform for infant cry analysis to translate needs and detect early signs of health conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, NLP & Conversational AI, Health IoT, Consumer Electronics

Business Model

B2B2C

Customer Profile

Subscription SaaS, Data as a Service, Services & Consulting

AI Layer

Application

Keywords

infant cry analysiscry translationbaby cry translatorvocal biomarkerneurodevelopmental disorder detectionearly pathology detectionbaby techsmart baby monitoracoustic analysisinfant health monitoringspeech development monitoringbaby monitor softwaredigital biomarkerhealth IoTB2B2C licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Zoundream Comparables

Compare Zoundream with similar companies based on industry and business-model similarity.

Zoundream comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Crynostics Inc.
83%
Ubenwa
82%
First Ascent Inc.
64%

Zoundream Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 3, 2025

Key People

Founding team and executive leadership

Roberto Iannone

CEO & Co-Founder

Founding Team

Zoundream Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 79% MoM, reaching 1.5K.

  • Jul 24, 2026

    Monthly visitors increased 154% MoM.

Zoundream Filings

Explore SEC and related filing metadata, where available.

Zoundream filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Zoundream's valuation, stock price, and market status.

Is Zoundream a public or private company?

Zoundream is a private company.

What is the current stock price of Zoundream?

Zoundream is a private company with no public stock price. No recent secondary market data is available.

How much is Zoundream worth (valuation)?

Valuation information for Zoundream is not publicly available.

Can I buy Zoundream stock?

Zoundream shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Zoundream's last funding round?

Zoundream's most recent funding round was Seed on October 3, 2025.

Who are the main investors in Zoundream?

Key investors in Zoundream include Granatus Ventures, Secways, Verge HealthTech Fund, Mission Gate, Center for Technological Development and Innovation.

Will Zoundream IPO soon?

No public IPO plans have been announced for Zoundream.

How can I track Zoundream secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Zoundream's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBasel
Employee Range18
Year Founded2018
Last FundingOct 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?